Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Completed 5Withdrawn 3Unknown 3Terminated 2Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Neoplasms 1Cardiovascular Abnormalities 1Cardiotoxicity 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × OTHER × Carvedilol × Clear all
NCT04939883 2024-06-28

CardioTox

Hospital Sirio-Libanes

Phase 4 Unknown
1,018 enrolled

Neoplasms, Cardiotoxicity

NCT02993198 2024-06-03

A Prospective Study of Breast Cancer Patients With Abnormal Strain Imaging

Northwestern University

Phase 2 Unknown
134 enrolled

Cardiovascular Abnormalities

NCT02944201 2021-02-21

Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate

Montefiore Medical Center

Phase 2 Unknown
22 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡